DEPLOYDatabase

Partnership

Medra x Genentech

Genentech leverages Medra's Physical AI, Scientific AI, and robotics platform to accelerate drug discovery. Medra integrates with Genentech's LIMS and ML infrastructure for continuous learning, enabling in-house predictions, experiment execution, and iterative optimization.

deployment · Active · operating

Track Medra x Genentech

Machine-readable surfaces

cdcff2da-b3b1-4c8e-b8d6-edb4ad57513f
Type
deployment
Status
Activeoperating
Announced
2025-12-11
9 months ago
Start
2025-12-11
9 months ago
Active for
9 months

Who’s involved

Medratechnology provider

Medra is building the first [Physical AI Scientist](https://www.medra.ai) — a closed-loop system that tightly integrates AI scientific reasoning with autonomous wet-lab experimentation. Founded in 2022, the San Francisco company operates [ML001](/models/ml001), a 38,000 sq ft autonomous lab where hundreds of off-the-shelf robots run continuous experiments across antibody discovery, protein engineering, gene editing, and cell biology. Partners including Genentech, Addition Therapeutics, Cultivarium, and DARPA access the platform through on-site deployments or remote operation.

HQSan Francisco, California, USAmedrallc.com2 partnerships

Off-registry parties

  • Genentech · customer

Related partnerships

Other deals between the same parties

Other partnerships of Medra

Recent partnerships of the same kind

Sources (1)

  1. https://www.mobihealthnews.com/news/medra-raises-52m-partners-genentech

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.